Speechlessness in acute oncology therapy - A longitudinal survey

• Conditions: Speechlessness; C00-C97; Malignant neoplasms

• Registration Number: DRKS00027973
• Lead Sponsor: niversitätsklinikum Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-14
• Study Completion: 2023-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Cancer diagnosis date at time of survey < 120 Tage

Oncological diagnosis

Exclusion Criteria

1. age < 18 years
2. diagnosis more than six weeks ago (42 days)
3. lack of knowledge of the German language comprehensibility/response to the consent form and the survey of the survey instrument due to the language barrier possible.
4. severe symptoms of illness (pain, etc.), which make it impossible to participate in the survey. Limitations) that do not allow participation in the study.
5. poor prognosis of the course of the disease, which does not allow an interview at the second time of the survey.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expression of speechlessness about the course of the disease (scale expression of the modules of the Kölner Fragebogen zur Sprachlosigkeit).

Secondary Outcome Measures

Name	Time	Method
To investigate whether the concept of speechlessness, as measured by the construct of the Kölner Fragebogen zur Sprachlosigkeit, is a personality trait that is stable over time (trait) or a situational influencing factor (state).